Dynamic Technology Lab’s Akebia Therapeutics AKBA Stock Holding History

Dynamic Technology Lab’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-76,324	Closed	-$173K	–	1069
2021 Q4	$173K	Buy	+76,324	New	+$208K	0.02%	983
2021 Q2	–	Sell	-96,016	Closed	-$325K	–	1096
2021 Q1	$325K	Buy	96,016 +78,183	+438%	+$282K	0.04%	772
2020 Q4	$50K	Sell	17,833 -61,407	-77%	-$179K	0.01%	928
2020 Q3	$199K	Buy	+79,240	New	+$695K	0.03%	808
2020 Q2	–	Sell	-18,787	Closed	-$142K	–	947
2020 Q1	$142K	Buy	+18,787	New	+$146K	0.03%	844
2019 Q1	–	Sell	-38,767	Closed	-$215K	–	950
2018 Q4	$215K	Buy	38,767 +27,778	+253%	+$217K	0.04%	795
2018 Q3	$97K	Sell	10,989 -25,545	-70%	-$228K	0.01%	953
2018 Q2	$365K	Buy	36,534 +10,978	+43%	+$110K	0.06%	585
2018 Q1	$243K	Buy	+25,556	New	+$357K	0.04%	800
2017 Q4	–	Sell	-21,115	Closed	-$415K	–	980
2017 Q3	$415K	Buy	+21,115	New	+$325K	0.07%	529
2017 Q1	–	Sell	-14,518	Closed	-$151K	–	942
2016 Q4	$151K	Buy	+14,518	New	+$125K	0.04%	771
2016 Q3	–	Sell	-19,629	Closed	-$147K	–	858
2016 Q2	$147K	Buy	+19,629	New	+$171K	0.04%	762

Other funds holding AKBA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OCM

Orchard Capital Management Chicago, Illinois $95.9M AUM 45.49% 1-Year Est. Return

Dynamic Technology Lab's AKBA Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Akebia Therapeutics (AKBA) in Q1 2022, closing a stake of 76,324 shares — an estimated $173K sold.

Dynamic Technology Lab first reported a position in AKBA in Q2 2016 and held it in 12 quarters. The position peaked at $415K in Q3 2017. 124 funds tracked by Wall St. Rank hold AKBA as of Q1 2022.

Dynamic Technology Lab reported no remaining Akebia Therapeutics position as of Q1 2022 after selling out during the quarter.
Dynamic Technology Lab sold 76,324 Akebia Therapeutics shares in Q1 2022, an estimated $173K.
Dynamic Technology Lab first reported a position in Akebia Therapeutics in Q2 2016 and held it in 12 quarters.
Dynamic Technology Lab's Akebia Therapeutics position peaked at $415K in Q3 2017.
124 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.